Route of administration (Number of patients = 382 (%) | ||
---|---|---|
Oral n = 176 (46.1%) | Parenteral n = 206 (53.9%) | |
Antibiotic group (n) | p-value = 0.002 | |
Aminoglycosides (10) | 0 | 10 (100.0) |
Penicillin (28) | 10 (35.7) | 18 (64.5) |
Cephalosporins (92) | 41 (44.6) | 51 (55.4) |
Carbapenems (5) | 0 | 5 (100.0) |
β-lactam/β-lactamase inhibitor (88) | 46 (52.3) | 42 (47.7) |
Lincosamides (51) | 28 (54.9) | 23 (45.1) |
Macrolides (1) | 1 (50.0) | 1 (50.0) |
Fluoroquinolones (53) | 30 (56.6) | 23 (43.4) |
Nitroimidazoles (51) | 17 (33.3) | 34 (66.7) |
Nitrofurantoin (2) | 2 (100.0) | 0 |
Folate inhibitors (1) | 1 (100.0) | 0 |
Duration of antibiotic intake / day | ||
Median (range) | 6 (0–89) | 4 (1–33) |
[IQR] | [3–9] | [2–7] |